1. MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms

   • Serena Capelli
   • Anna Caroli
   • Simonetta Gerevini

   Original Communication 19 January 2023 Pages: 1195 - 1206

   

2. Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine

   • Chiara Briani
   • Sergio Ferrari
   • Andrea Visentin

   Letter to the Editors 10 November 2022 Pages: 1207 - 1210

   

3. Persistent hiccups as main COVID-19 manifestation with transient cytotoxic lesion of the corpus callosum splenium during the Omicron wave in the post-vaccination era

   • Celeste Sassi
   • Emel Mehmed
   • Hans-Michael Schmitt

   Letter to the Editors Open access 18 November 2022 Pages: 1211 - 1214

   

4. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort

   • Ann-Katrin Schild
   • Yasemin Goereci
   • Franziska Maier

   Original Communication Open access 23 November 2022 Pages: 1215 - 1223

   

5. A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection

   • Massimo Barbagallo
   • Dominik Straumann
   • Anton Schmick

   Letter to the Editors 28 December 2022 Pages: 1224 - 1228

   

6. Gene mutations in comorbidity of epilepsy and arrhythmia

   • Cheng Yu
   • Xue-jun Deng
   • Da Xu

   Review 14 November 2022 Pages: 1229 - 1248

7. Clinical differences between menstrual migraine and nonmenstrual migraine: a systematic review and meta-analysis of observational studies

   • Miao Wang
   • Guoliang Zhu
   • Fanyi Kong

   Review 14 November 2022 Pages: 1249 - 1265

   

8. Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis

   • Omid Mirmosayyeb
   • Robert Zivadinov
   • Dejan Jakimovski

   Review 17 November 2022 Pages: 1266 - 1285

   

9. Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective

   • Massimo Filippi
   • Paolo Preziosa
   • Maria A. Rocca

   Review Open access 24 November 2022 Pages: 1286 - 1299

   

10. Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review

    • Robert Simpson
    • Stephanie Posa
    • Anthony Feinstein

    Review Open access 29 November 2022 Pages: 1300 - 1322

    

11. Towards clinical application of implantable brain–computer interfaces for people with late-stage ALS: medical and ethical considerations

    • Mariska J. Vansteensel
    • Eran Klein
    • Theresa M. Vaughan

    Review Open access 30 November 2022 Pages: 1323 - 1336

    

12. Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective

    • Sebastian Lucas

    Review Open access 02 December 2022 Pages: 1337 - 1345

    

13. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications

    • Luca Soraci
    • Maria Elsa Gambuzza
    • Silvia Marino

    Review Open access 03 December 2022 Pages: 1346 - 1360

    

14. Restless legs syndrome and cognitive function among adults: a systematic review and meta-analysis

    • Shichan Wang
    • Xiaoting Zheng
    • Huifang Shang

    Review 06 December 2022 Pages: 1361 - 1370

    

15. Adaptive deep brain stimulation for Parkinson’s disease: looking back at the past decade on motor outcomes

    • Qi An
    • Zixiao Yin
    • Jianguo Zhang

    Review 06 December 2022 Pages: 1371 - 1387

    

16. Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial

    • Irina Galperin
    • Anat Mirelman
    • Jeffrey M. Hausdorff

    Original Communication 11 November 2022 Pages: 1388 - 1401

    

17. Neuronal networks underlying ictal and subclinical discharges in childhood absence epilepsy

    • Ami Kumar
    • Ekaterina Lyzhko
    • Natia Japaridze

    Original Communication Open access 12 November 2022 Pages: 1402 - 1415

    

18. Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological–serological correlative study

    • Anne-Sophie Dietmann
    • Niels Kruse
    • Imke Metz

    Original Communication Open access 13 November 2022 Pages: 1416 - 1429

    

19. Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis

    • Silje Andreassen
    • Elisabeth Margrete Stokke Lindland
    • Randi Eikeland

    Original Communication Open access 15 November 2022 Pages: 1430 - 1438

    

20. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients

    • Fei Peng
    • Huayan Xu
    • Lianggeng Gong

    Original Communication 16 November 2022 Pages: 1439 - 1451

    

21. Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance

    • Andrea Fortuna
    • Daniele Sabbatini
    • Gianni Sorarù

    Original Communication Open access 16 November 2022 Pages: 1452 - 1456

    

22. Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis

    • Sohyeon Kim
    • Ki Hoon Kim
    • Seung Woo Kim

    Original Communication 16 November 2022 Pages: 1457 - 1465

    

23. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    • Kiran Samra
    • Amy M. MacDougall
    • the Genetic FTD Initiative (GENFI)

    Original Communication Open access 17 November 2022 Pages: 1466 - 1477

    

24. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis

    • Young Nam Kwon
    • Mark Woodhall
    • Yoon-Ho Hong

    Original Communication Open access 17 November 2022 Pages: 1478 - 1486

    

25. Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer’s disease by integrated bioinformatics

    • Yang Li
    • Zuolong Chen
    • Feng Gao

    Original Communication 18 November 2022 Pages: 1487 - 1500

    

26. Exome-based gene panel analysis in a cohort of acute juvenile ischemic stroke patients:relevance of NOTCH3 and GLA variants

    • Johanna Härtl
    • Julia Hartberger
    • Marcus Deschauer

    Original Communication Open access 21 November 2022 Pages: 1501 - 1511

    

27. Heterogeneity of persisting symptoms after sport-related concussion (SRC): exploring symptom subtypes and patient subgroups

    • S. Langdon
    • E. Goedhart
    • M. Königs

    Original Communication Open access 21 November 2022 Pages: 1512 - 1523

    

28. Botulinum toxin antibody titres: measurement, interpretation, and practical recommendations

    • Dirk Dressler
    • John C. Rothwell
    • Fereshte Adib Saberi

    Original Communication Open access 24 November 2022 Pages: 1524 - 1530

    

29. MRI spot sign in acute intracerebral hemorrhage: an independent biomarker of hematoma expansion and poor functional outcome

    • Nefeli Valyraki
    • Adrien Goujon
    • Pierre Seners

    Original Communication 25 November 2022 Pages: 1531 - 1542

    

30. Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis

    • Paolo Preziosa
    • Maria A. Rocca
    • the CogEx Research Team

    Original Communication 27 November 2022 Pages: 1543 - 1563

    

31. Onset and mortality of Parkinson’s disease in relation to type II diabetes

    • Gianni Pezzoli
    • Emanuele Cereda
    • Ioannis U. Isaias

    Original Communication Open access 27 November 2022 Pages: 1564 - 1572

    

32. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    • Agnès Pérez-Millan
    • Sergi Borrego-Écija
    • The Genetic FTD Initiative, GENFI

    Original Communication 29 November 2022 Pages: 1573 - 1586

    

33. Proximal hyperdense middle cerebral artery sign is associated with increased risk of asymptomatic hemorrhagic transformation after endovascular thrombectomy: a multicenter retrospective study

    • Zhiming Kang
    • Lishuo Wu
    • Junjian Zhang

    Original Communication Open access 29 November 2022 Pages: 1587 - 1599

    

34. Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies

    • Daniel Baumgartner
    • Radim Mazanec
    • Jitka Hanzalová

    Original Communication 01 December 2022 Pages: 1600 - 1614

    

35. Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia

    • David R. Lynch
    • Katherine D. Mathews
    • Mark Midei

    Original Communication 03 December 2022 Pages: 1615 - 1623

    

36. Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis

    • Marco Ganzetti
    • Jennifer S. Graves
    • Michael Lindemann

    Original Communication Open access 05 December 2022 Pages: 1624 - 1636

    

37. White matter hyperintensities are an independent predictor of cognitive decline 3 years following first-ever stroke—results from the PROSCIS-B study

    • Huma Fatima Ali
    • Lea Fast
    • Anna Kufner

    Original Communication Open access 06 December 2022 Pages: 1637 - 1646

    

38. Vasoconstriction and long-term headache in reversible cerebral vasoconstriction syndrome

    • Neha Kumar
    • Sandeep Kumar
    • Vasileios-Arsenios Lioutas

    Original Communication 06 December 2022 Pages: 1647 - 1653

39. Profile of precipitating factors and its implication in 160 Indian patients with Moyamoya angiopathy

    • Shambaditya Das
    • Biman Kanti Ray
    • Markus Kraemer

    Original Communication 07 December 2022 Pages: 1654 - 1661

40. Diffusion tensor imaging of the brain in Pompe disease

    • Jan J. A. van den Dorpel
    • Marjolein H. G. Dremmen
    • Johanna M. P. van den Hout

    Original Communication Open access 08 December 2022 Pages: 1662 - 1671

    

41. The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis

    • Matteo Albergoni
    • Loredana Storelli
    • Massimo Filippi

    Original Communication 12 December 2022 Pages: 1672 - 1681

    

42. Analysis of brain and spinal MRI measures in a common domain to investigate directional neurodegeneration in motor neuron disease

    • C. Toh
    • A. Keslake
    • T. M. Jenkins

    Original Communication Open access 12 December 2022 Pages: 1682 - 1690

    

43. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques

    • Marco Vabanesi
    • Anne-Laurie Pinto
    • Sergio Muñiz-Castrillo

    Original Communication 13 December 2022 Pages: 1691 - 1701

    

44. Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

    • Danielle J. Leighton
    • Morad Ansari
    • and the CARE-MND Consortium

    Original Communication Open access 14 December 2022 Pages: 1702 - 1712

    

45. Generalized vestibular hyporeflexia and chronic upbeat nystagmus due to thiamine deficiency

    • William Zhu
    • Kristen K. Steenerson
    • Jorge C. Kattah

    Original Communication 15 December 2022 Pages: 1713 - 1720

    

46. Effect of robotic tilt table verticalization on recovery in patients with disorders of consciousness: a randomized controlled trial

    • M. J. Rosenfelder
    • V. C. Helmschrott
    • A. Bender

    Original Communication Open access 19 December 2022 Pages: 1721 - 1734

    

47. Cerebellar alterations in Parkinson’s disease with postural instability and gait disorders

    • Andrea Gardoni
    • Federica Agosta
    • Massimo Filippi

    Original Communication 19 December 2022 Pages: 1735 - 1744

    

48. Congestive myelopathy due to craniocervical junction arteriovenous fistulas mimicking transverse myelitis: a multicenter study on 27 cases

    • Keisuke Takai
    • Toshiki Endo
    • the Neurospinal Society of Japan CCJAVF Study Investigators

    Original Communication 19 December 2022 Pages: 1745 - 1753

    

49. Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders

    • Alessandro Dinoto
    • Enrico Marcuzzo
    • Michele Tinazzi

    Short Commentary 12 November 2022 Pages: 1754 - 1758

    

50. Use of remote monitoring and integrated platform for the evaluation of sleep quality in adult-onset idiopathic cervical dystonia

    • Grace A. Bailey
    • Clare Matthews
    • Kathryn J. Peall

    Short Commentary Open access 21 November 2022 Pages: 1759 - 1769